Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Cardiac-Induced Edema
NCT01618448Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Jul 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in edema secondary to heart failure, sponsored by Otsuka Holdings. Started Jul 2012; status: completed.
02
Drugs
tolvaptan
03
Conditions
edema secondary to heart failure
Beyond the preview
Go deeper on NCT01618448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01618448.